ShareValue scores for OPTH: Valuation 42, Quality 55, Growth 61, Health 54.

OPTH
NASDAQ

Optimi Health Corp. Common Shares

$5.15(+1.98%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
42
Fair Value
Price vs Value
Quality
55
Moderate
Business Strength
Growth
61
Moderate
Revenue & Earnings
Health
54
Moderate
Financial Stability
Momentum
37
Bearish
Price Trend

Company Details

About

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026